Evidence map›Paper›PMID 39193503›Full record

ArticleFrontiers in cellular and infection microbiology2024

Cloaking antibodies are prevalent in

Amy Pham, Kellynn K Y Tan, Emma L Ledger, Daniel J Smith, David W Reid, Lucy Burr, Daniel C Chambers, Timothy J Wells

Abstract read
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Opsonization Improves Dual Proteomic Analysis ofJournal of proteome research · 2026
    Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Amy PhamFrazer Institute, The University of Queensland, Brisbane, QLD, Australia.
Kellynn K Y TanFrazer Institute, The University of Queensland, Brisbane, QLD, Australia.
Emma L LedgerFrazer Institute, The University of Queensland, Brisbane, QLD, Australia.
Daniel J SmithFaculty of Medicine, The University of Queensland, Brisbane, QLD, Australia.
David W ReidThe Adult Cystic Fibrosis Centre and Department of Thoracic Medicine, The Prince Charles Hospital, Brisbane, QLD, Australia.
Lucy BurrDepartment of Respiratory Medicine, Mater Health, South Brisbane, QLD, Australia.
Daniel C ChambersFaculty of Medicine, The University of Queensland, Brisbane, QLD, Australia.
Timothy J WellsFrazer Institute, The University of Queensland, Brisbane, QLD, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: The Methods: Twelve Results: We found that several of the Discussion: Cloaking antibodies are prevalent in patients with

Indexed as

AntibodiesBurkholderia cepacia complexBurkholderia InfectionsAntibodies, BlockingBlood Bactericidal ActivityCystic FibrosisGenome, BacterialHumansLipopolysaccharidesProspective StudiesAntibodiesAntibodies, BlockingLipopolysaccharidesantibodyBurkholderia cepacia complexcepacia syndromecomplementcystic fibrosisserum resistance

Identifiers

PMID39193503
PMCPMC11347948

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.